ESSA Pharma Balance Sheet Health
Financial Health criteria checks 6/6
ESSA Pharma has a total shareholder equity of $124.6M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $128.1M and $3.5M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$126.76m |
| Equity | US$124.61m |
| Total liabilities | US$3.51m |
| Total assets | US$128.11m |
Recent financial health updates
Companies Like ESSA Pharma (NASDAQ:EPIX) Are In A Position To Invest In Growth
Aug 21
We're Not Very Worried About ESSA Pharma's (NASDAQ:EPIX) Cash Burn Rate
Feb 18ESSA Pharma (NASDAQ:EPIX) Is In A Good Position To Deliver On Growth Plans
Aug 16We're Hopeful That ESSA Pharma (NASDAQ:EPIX) Will Use Its Cash Wisely
Dec 15Recent updates
Companies Like ESSA Pharma (NASDAQ:EPIX) Are In A Position To Invest In Growth
Aug 21We're Not Very Worried About ESSA Pharma's (NASDAQ:EPIX) Cash Burn Rate
Feb 18ESSA Pharma (NASDAQ:EPIX) Is In A Good Position To Deliver On Growth Plans
Aug 16Estimating The Fair Value Of ESSA Pharma Inc. (NASDAQ:EPIX)
Jan 25We're Hopeful That ESSA Pharma (NASDAQ:EPIX) Will Use Its Cash Wisely
Dec 15ESSA Pharma: Update Including Clinical Collaboration Agreement With Janssen
Feb 02ESSA Pharma and Janssen to test combo treatments in prostate cancer setting
Jan 13ESSA Pharma EPS beats by $0.02
Dec 15Financial Position Analysis
Short Term Liabilities: EPIX's short term assets ($127.6M) exceed its short term liabilities ($3.3M).
Long Term Liabilities: EPIX's short term assets ($127.6M) exceed its long term liabilities ($205.2K).
Debt to Equity History and Analysis
Debt Level: EPIX is debt free.
Reducing Debt: EPIX has no debt compared to 5 years ago when its debt to equity ratio was 7.6%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: EPIX has sufficient cash runway for more than 3 years based on its current free cash flow.
Forecast Cash Runway: EPIX has sufficient cash runway for 1.7 years if free cash flow continues to reduce at historical rates of 13.2% each year.
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/26 11:54 |
| End of Day Share Price | 2024/12/24 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2024/09/30 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
ESSA Pharma Inc. is covered by 8 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Joseph Pantginis | H.C. Wainwright & Co. |
| Maurice Raycroft | Jefferies LLC |
| Soumit Roy | JonesTrading Institutional Services, LLC |